Viral Vectors
Technologies
Gene Therapy & Vaccination
Partners
About us

Seite wählen

Home / About us / Newsroom

Newsroom

If you like to receive our Newsletter directly by email, please subscribe here.

Newsletter
Press Releases
News of Interest
Media Coverage
Investor News

Management
FAQ
Company
References
Newsroom
Investors
Careers
Contact us

contact us

Contact us

Whether you seek help customizing a vector for academic use or support for your industrial R&D, we will assist you from square one to discuss and plan your project in detail.

News

SIRION Biotech Licenses Adenovirus Technology to Danish Startup, InProTher for its Novel Immunotherapy Design Targeting Endogenous Retrovirus (ERV) Learn More

Meet us at

Annual meeting of the SFTCG 2020

MAR 11-13 LYON, France

Making gene therapy a clinical reality DG-GT 2020

MAR 16-18 HANNOVER, Germany

ASGCT 2020

MAY 9-11 BOSTON, US

Follow us

Google
Facebook
Twitter
Linkedin

Newsletter

SIRION Biotech’s Viral Vector Technologies for every application, from gene therapy and vaccination development to customization of cell modeling tools.

Viral Vectors
Technologies
Gene Therapy & Vaccination
Partners
About us
- About us
- Contact us
- Company
- Management
- Newsroom
- References
- FAQ
- Careers
- Investors
- Terms
- Legal / Impressum
- Privacy Statement

© Sirion-Biotech GmbH 2020

Terms
Legal / Impressum
Privacy Statement